NEW YORK (GenomeWeb) – As part of an effort to build a Small Cell Lung Cancer (SCLC) Consortium, National Cancer Institute announced that it intends to fund research that will support the development of new molecular diagnostics and screening approaches for populations at high risk of developing the disease.

The agency said that approved projects may receive up to $450,000 in annual direct costs for up to five years, with the total number of awards depending on National Institutes of Health appropriations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sponsored by

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.